In effort to tackle coronavirus, Northwestern Medicine launches antiviral drug trial

The first participants have been enrolled by Illinois-based Northwestern Medicine in a new clinical drug trial that aims to tackle coronavirus.

“The drug being tested is remdesivir, a novel antiviral drug developed to treat Ebola and which has subsequently been found, in animal models, to have antiviral activity against coronaviruses including MERS and now SARS-Cov-2, the virus that causes [the] COVID-19 disease,” Northwestern Medicine told Fox News. “The randomized, placebo-controlled, double-blind trial will evaluate the safety and efficacy of the drug in hospitalized adult patients diagnosed with COVID-19.”

The medical system explained that the first Chicago-area patient to receive the drug at Northwestern Memorial Hospital is an 89-year-old man in intensive care.

More

https://www.foxnews.com/science/coronavirus-northwestern-medicine-launches-antiviral-drug-trial